Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | NPC1 | O15118 | 4/20 | 0.40 |
| ▸ | RAB9A | P51151 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12838589 | 0.90 | CYP1A2 (0.52) | CYP1A2CYP3A4CYP2C19GAAKDM4E | |
| SCHEMBL12839739 | 0.87 | CYP1A2 (0.40) | CYP1A2CYP3A4CYP2C19GAAKDM4E | |
| SCHEMBL12838742 | 0.87 | CYP1A2 (0.40) | CYP1A2CYP3A4CYP2C19GAAKDM4E | |
| SCHEMBL12839118 | 0.87 | CYP1A2 (0.51) | CYP1A2CYP3A4CYP2C19GAAKDM4E | |
| SCHEMBL13068089 | 0.86 | MAPK14 (0.45) | GAAKDM4EHTTLMNAHPGD | |
| SCHEMBL12840512 | 0.85 | CYP1A2 (0.49) | CYP1A2CYP3A4CYP2C19GAAKDM4E | |
| SCHEMBL12840241 | 0.85 | MAPT (0.52) | CYP1A2CYP3A4CYP2C19KDM4ECYP2C9 | |
| SCHEMBL12839420 | 0.84 | CYP1A2 (0.48) | CYP1A2CYP3A4CYP2C19GAAKDM4E | |
| SCHEMBL12839692 | 0.84 | KMT2A (0.43) | GAAMAOBALDH1A1NPC1RAB9A | |
| SCHEMBL13067707 | 0.84 | ALOX5 (0.53) | CYP1A2CYP3A4CYP2C19GAAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110070656-A1 | Fluorescent Proteins | JNC CORPORATION (JP) | 2011-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110070656-A1 | Fluorescent Proteins | CACYBP, CHLSN, LCP2 | CYP1A2 4017/4885CYP3A4 1812/4885CYP2C19 4355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.